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Summary
Objective: Studies on the biology of the human meniscus cell are scarce. The objective of our studies was to assess survival/proliferation of
human meniscus cells in different culture conditions and to characterize the extracellular matrix (ECM) produced by these cells in these
artiﬁcial environments. The composition of this ECM offers a variable to deﬁne the distinct meniscus cell phenotype.
Materials and methods: Human meniscus cells were isolated enzymatically from visually intact lateral and medial knee menisci. Cells were
cultured in monolayer conditions or in alginate gel. The composition of the cell-associated matrix (CAM) accumulated by the isolated cells
during culture was investigated and compared to the CAM of articular chondrocytes cultured in alginate using ﬂow cytometry with ﬂuorescein
isothiocyanate-conjugated monoclonal antibodies against type I collagen, type II collagen and aggrecan. Additional cell membrane markers
analysis was performed to further identify the different meniscus cell populations in the alginate culture conditions and meniscus tissue
sections. Proliferation was analyzed using the Hoechst 33258 dye method. In some experiments, the effect of TGFb1 on some of these
variables was investigated.
Results: The CAM of monolayer cultured meniscus cells is composed of high amounts of type I and II collagen and low amounts of aggrecan.
A major population of alginate cultured meniscus cells on the other hand synthesized a CAM containing high amounts of type I collagen, low
amounts of type II collagen and high amounts of aggrecan. This population is CD44CCD105CCD34CD31. In contrast, a minor cell
population in the alginate culture did not accumulate ECM and was mainly CD34C. The CAM of alginate cultured articular chondrocytes is
composed of low amounts of type I collagen, high amounts of type II collagen and aggrecan. The expression of aggrecan and of type II
collagen was increased by the addition of TGFb1 to the culture medium. The proliferation of meniscus cells is increased in the monolayer
culture conditions. Cell numbers decrease slightly in the alginate culture, but can be increased after the addition of TGFb1.
Conclusion: These results demonstrate that the human meniscus is populated by different cell types which can be identiﬁed by a distinct CAM
composition and membrane marker expression. Unlike the monolayer culture conditions, the alginate culture conditions appear to favor
a more ﬁbrochondrocyte-like cell accumulating a CAM resembling the native tissue composition. This CAM composition is distinctly different
from the CAM composition of phenotypically stable articular cartilage chondrocytes cultured in the same alginate matrix.
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The meniscus plays an important role in the complex
biomechanics of the knee joint. It has functions in load
bearing, load transmission, shock absorption, joint stability,
joint lubrication and joint congruity. The function of the
meniscus is reﬂected in its cellular and biochemical
composition in such a way that shear stresses, compressive
forces, tensile hoop stresses and circumferentially directed
forces are redirected properly. Knee meniscal ﬁbrocartilagi-
nous tissue contains mainly water (72%), collagens (22%)
and glycosaminoglycans (0.8%)1,2. Type I collagen accounts
for over 90% of the total collagen content. Type II, III and V
collagen are the remaining meniscal collagens3,4. The
peripheral two-thirds of the meniscus solely consist of type
I collagen, whereas type II collagen comprises a signiﬁcant
portion of the ﬁbrillar collagen in the inner meniscus5. Type III
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Received 14 May 2004; revision accepted 24 January 2005.548and V collagen are trace elements in the peripheral part of
the meniscus. Type I collagen ﬁbers are radially and
circumferentially orientated, providing resistance to tensile
forces6. Aggrecan is a major proteoglycan in meniscal
tissue7 and aggrecan aggregate content is higher in the inner
and middle part than in the peripheral part of the meniscus8.
Aggrecan plays an important role in the maintenance of
optimal viscoelastic behavior, compressive stiffness and
tissue hydration. Other proteoglycans present are ﬁbromo-
dulin, biglycan and decorin9. The biochemical constitution of
the extracellular matrix (ECM) is a direct reﬂection of the
tissue adaptation to local loads and is built up by the sparsely
distributed meniscus cells, whose DNA accounts for 0.12%
of the total wet weight of meniscal tissue1.
Current concepts on meniscus cell biology indicate the
existence of at least two cell populations in the human
meniscus10. The main cell type in the inner and middle part
of the meniscus has been termed the ﬁbrochondrocyte4.
This cell is deﬁned as round or oval shaped surrounded by
an abundant ECM4,10. The outer one-third of the meniscus
is populated by mainly ﬁbroblast-like cells within a dense
connective tissue10. The outer portion of the meniscus is
549Osteoarthritis and Cartilage Vol. 13, No. 7also characterized by the presence of vascular and nervous
elements11,12. This is in contrast to the middle and inner
part of the meniscus which is avascular, aneural and
alymphatic. Due to the absence of vasculature, lesions
located in the inner and middle part of the meniscus have
less repair and regeneration potential than lesions located
in the outer one-third.
Loss of meniscus tissue results in higher peak stresses
on the articular cartilage and eventually leads to cartilage
degeneration and osteoarthrosis13. This cartilage degener-
ation is directly proportional to the amount of meniscus that
was removed14.
Tissue engineering could be an alternative and promising
option for the treatment of meniscus defects. Tissue
engineering is based on three basic ingredients: scaffolds,
growth factors and cells. An obvious cell type for this
therapeutical approach would be the meniscus cell. Since
our knowledge about meniscus cell biology and behavior
in vitro and in vivo is very limited, these investigations aimed
at the characterization of the proliferation potential of the
meniscus cell and the accumulation of the cell-associated
ECM. The CAM is an integral part of the larger pericellular or
territorial matrix of the meniscus cell. The biochemical
composition of this CAM can easily be identiﬁed with ﬂow
cytometry and is an instant reﬂection of the cellular
phenotype15. Ultimately, this cellular phenotype determines
the biochemical and biomechanical characteristics of the
tissue engineered construct. Since type I collagen, type II
collagen and aggrecan are three important ECM compo-
nents, these molecules were chosen to be analyzed in the
CAM. The investigations were performed on two different
culture conditions: the monolayer culture and the culture in
alginate hydrogel. The former allowed articular cartilage
chondrocytes to proliferate and dedifferentiate. The latter
allows low proliferation of articular cartilage chondrocytes
maintaining their original phenotype. In parallel with the
investigations on articular cartilage chondrocytes, the
metabolic characteristics and behavior of human knee
meniscus cells were investigated in both culture conditions.
Materials and methods
MENISCUS CELL ISOLATION
Complete, visually intact human lateral and medial
menisci were harvested 24 h postmortem in accordance
with the currently accepted transplantation protocol of the
hospital and approved by the local ethics committee. All
donors had died after a short disease. None received
corticosteroids or cytostatic drugs.
Menisci were inspected macroscopically for gross de-
generation. Anterior and posterior entheses and all synovial
tissue were carefully trimmed by sharp dissection. The
specimens were then diced into 1! 1! 1 mm pieces.
In order to obtain a single cell suspension these pieces
were enzymatically digested for 4e6 h with 3 mg/ml colla-
genase grade II (Clostridium histolyticum, ICN Biomedicals
Inc., Aurora, Ohio, USA) in Dulbecco’s Modiﬁed Eagle’s
Medium (DMEM, GIBCO Invitrogen Co, Merelbeke, Bel-
gium), supplemented with 10% fetal bovine serum (FBS,
GIBCO Invitrogen Co), antibiotics and antimycotics (penicil-
lin 10 U/ml, streptomycin 10 mg/ml, fungizone 0.025 mg/ml)
(GIBCO Invitrogen Co), 0.002 M L-glutamine followed by the
addition for 1e2 h of 2 mg/ml pronase (Streptomyces griseus
pronase E, Merck, Darmstadt, Germany) in DMEM, anti-
biotics and antimycotics, 0.002 M L-glutamine16. Cells were
washed, ﬁltered and resuspended in Hank’s balanced saltsolution without Ca2C or Mg2C (HBSS, GIBCO Invitrogen
Co) at the appropriate concentration depending on the
culture conditions. Cells were counted and viability checked
using trypan blue exclusion test. Forty to 50 million cells
could be isolated from two medial and two lateral menisci
from one donor. Over 90% of the isolated cells were viable.
ARTICULAR CHONDROCYTE ISOLATION
Human articular chondrocytes were isolated from the
same donors as described elsewhere, with a few modiﬁca-
tions17. Intact cartilage removed from the femoral condyles
was diced into small fragments and chondrocytes were
isolated by sequential enzymatic digestion (hyaluronidase,
pronase and collagenase) of the ECM as described in
detail18. Cells were washed, ﬁltered and resuspended in
HBSS without Ca2C or Mg2C at the appropriate concentra-
tion depending on the culture conditions. Cells were counted
and viability checked using trypan blue exclusion test.
THREE-DIMENSIONAL CULTURE IN ALGINATE HYDROGEL
Meniscus cell and articular chondrocyte cultures in
alginate were prepared as described elsewhere, with some
modiﬁcations19. Cells suspended in one volume of HBSS
were carefully mixed with an equal volume of 2% (weight/
volume) alginate (low-viscosity alginate from Macrocystis
pyrifera, Sigma-Aldrich, St Louis, MO, USA) in HBSS
(previously autoclaved for 15 min), obtaining a ﬁnal con-
centration of 5! 106 cells/ml in 1% alginate. Alginate
beads formed when this cellealginate suspension was
carefully dropped in a 102 mM CaCl2 solution through a 23
Gauge needle. After a 10 min polymerization period, the
beads were washed twice in 0.9% NaCl and then cultured in
5 ml of culture medium (DMEM, antibiotics, FBS 10%,
L-glutamine, ascorbic acid 2-phosphate 50 mg/ml). The
culture medium was changed three times a week. The
cells were cultured in a 6-well plate (each well containing 30
beads,G1.5! 106 cells/well). In some experiments Trans-
forming Growth Factor (TGF) b1 (25 ng/ml ﬁnal concentra-
tion, R&D Systems, Minneapolis, USA) was added to the
meniscus cells cultured in alginate.
MENISCUS CELL MONOLAYER CULTURE
Cells were seeded in a T25 ﬂask (Nunc, Roskilde,
Denmark) at an initial density of 2! 105 cells/cm2. The
same culture medium was used for the cells cultured in the
alginate beads. Medium was changed three times a week.
When monolayer cultures became conﬂuent after 5e7
days of culture, cells were washed with phosphate buffered
saline without Ca2C and Mg2C (PBS, GIBCO Invitrogen Co)
prior to treatment with trypsineethylenediaminetetraacetic
acid (EDTA) (GIBCO Invitrogen Co) for 10 min. Culture
medium with 10% FBS was used to neutralize the
trypsineEDTA solution. The cell suspension was centri-
fuged (1500 rpm, 10 min) and washed with culture medium.
This allowed cell isolation with over 95% viability. Cells were
reseeded at an initial seeding density of 2! 104 cells/cm2.
MONOCLONAL ANTIBODIES
Monoclonal antibodies (mAb) against different ECM
proteins included mouse anti-human aggrecan20 (clone
969D4D11, IgG1, Biosource, Nivelles, Belgium), type I
(clone I-8H5, IgG2a, ICN Biomedicals Inc) and type II (clone
II-4CII, IgG1, ICN Biomedicals Inc) collagen
21. Mouse IgG1
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were used as isotype e matched negative controls.
The anti-human aggrecan mAb was shown to react
speciﬁcally with the G1-domain of the invariable hyalur-
onan-binding region of the human aggrecan molecule. No
cross-reactivity with other known matrix components has
been detected20e22. Anti-human type I and type II collagen
mAbs were raised in BALB/c mice after immunization with
human placental type I collagen and human costal cartilage
type II collagen, respectively. On Western blots anti-type I
collagen was shown to react speciﬁcally with the alpha
chain and the triple helix molecular form of type I collagen.
The anti-type II collagen mAb reacted speciﬁcally with the
alpha2(II) chain of human type II collagen21.
PREPARATION OF FITC-CONJUGATED mAb FOR
FLOW CYTOMETRY
Selected monoclonals were conjugated with ﬂuorescein
isothiocyanate isomer I (FITC, Sigma-Aldrich) for direct
immunoﬂuorescence as described with some modiﬁca-
tions23. Brieﬂy, 1 mg/ml of the antibody was conjugated with
FITC (0.2 mg/ml) in 0.5 M carbonate/bicarbonate buffer, pH
9.0 at 4(C in the dark during 24 h. Conjugated mAb were
separated from free FITC using Sephadex G-25 (Pharmacia,
Uppsala, Sweden) gel permeation HPLC chromatography in
PBS solution at pH 7.2. The optical density of the FITC-
conjugated antibodies was measured at 495 nm (FITC) and
280 nm (mAb) by spectrometry (Ultraspec 1000E, Pharma-
cia Biotech). The degree of conjugation was calculated
according to the following equation FITC/ProteinZ (2.87!
A495)/(A280 (0.35! A495)). Optimal conjugation requires
a ratio between 3 and 5. Conjugated antibodies were stored
at 4(C, in the dark, with 0.01% sodium azide.
CELL MEMBRANE MARKERS
Additional cell membrane markers were used during ﬂow
cytometric analysis to further identify the cell population
isolated from human meniscal tissue. All markers were
FITC-conjugated mAbs and used according to manufactur-
er’s instructions. FITCemAbs used were: FITCeCD31
(clone WM59, IgG1), FITCeCD34 (clone 581, IgG1),
FITCeCD44 (clone G44-26, IgG2b), FITCeCD45 (clone
HI30, IgG1), all from Becton Dickinson Pharmingen,
Erembodegem, Belgium and FITCeCD105 (clone SN6,
IgG1) from Serotec, Oxford, UK.
The expression of CD31, also named PECAM-1, is
limited to endothelial cells, platelets, leukocytes, and their
precursors24. CD34 is expressed on early lymphohemato-
poietic stem and progenitor cells, small-vessel endothelial
cells, embryonic ﬁbroblasts, and some cells in fetal and
adult nervous tissue24. CD44 serves as a recyclable
receptor for hyaluronan and is widely expressed on the
surface of most cell types, including articular cartilage
chondrocytes and bone marrow derived mesenchymal stem
cells24. CD45 is expressed on all hematopoietic cells24.
CD105 or endoglin modulates the cellular response to
TGFb1 and is expressed on many cell types including
endothelial cells, articular chondrocytes, bone marrow
derived mesenchymal stem cells, monocytes etc.24.
FLOW CYTOMETRIC ANALYSIS OF THE CAM OF CULTURED
MENISCUS CELLS AND ARTICULAR CHONDROCYTES
Meniscus cell cultures were analyzed on different time
points of culture (week 1, week 2 and week 3). Cellsobtained from at least three donors were tested for every
experimental condition. All tests were performed in three-
fold.
Articular cartilage chondrocytes, cultured in alginate for 7
days, served as control.
Cells cultured in alginate beads could be released from
the gel by the addition of 2 ml sodium citrate 55 mM to each
culture followed by gentle shaking. Ten milliliters of PBS
without Ca2C or Mg2C were then added to the cell
suspension prior to centrifugation.
Meniscus cells cultured in monolayer conditions were
harvested non-enzymatically by incubation with 1 mM
EDTA in PBS without Ca2C or Mg2C for 30 min15. It was
impossible to obtain a single cell suspension of the 3-week-
old monolayer cultures with the non-enzymatical protocol
due to cell clustering. Therefore, the analysis for this time
point for the monolayer cultures was omitted.
After centrifugation (1500 rpm, 10 min) the cell pellets
were resuspended in PBS without Ca2C or Mg2C. Hundred
microliters of this suspension was incubated with 10 ml of
the appropriate mAb (0.1 mg/ml) during 30 min. After
washing with 4 ml PBS without Ca2C or Mg2C cells were
analyzed on a FACSort (Becton Dickinson) using Cellquest
and WinMDI software. For each sample approximately
20,000 events were analyzed. Dead cells were excluded
using propidium iodide (PI) staining as previously de-
scribed25. Median cell ﬂuorescence intensity (MFI) values
were calculated per sample after binding of the mAbeFITC
complex to the speciﬁc epitopes. This was done by
subtracting the MFI of the negative control from the MFI
of the stained cell samples.
PROLIFERATION ASSAY
Meniscus cell proliferation was assayed by measuring the
DNA content per culture in threefold per time point, using the
Hoechst H 33258 dye method (Pharmacia Biotech Inc, San
Francisco, CA, USA)26. Cells were isolated from alginate
beads using sterilized sodium citrate solution or from
monolayer cultures using trypsineEDTA solution. Cells
were washed, pelleted and resuspended in 500 ml sterile
PBS without Ca2C or Mg2C and frozen at 80(C for further
analysis. Prior to analysis the frozen aliquots were thawed at
room temperature and sonicated for 1 min. A 40 ml sample
was added to a 2 ml Hoechst dye solution in TNE buffer (Tris
10 mM, NaCl 200 mM, EDTA Na2-2H2O 1 mM). Fluores-
cence was measured in a Hoefer dynaquant 200 ﬂuorom-
eter, using double strand calf thymus DNA (Sigma-Aldrich)
in PBS as a standard. The emission was measured at
460 nm for an excitation wavelength of 365 nm26.
HISTOLOGY
To analyze cell morphology, histology was performed on
both culture models as well as on native meniscus tissue.
Native meniscus tissue was ﬁxed in 4% aqueous para-
folmadehyde and embedded in parafﬁn. Alginate beads
were washed, ﬁxed in 4% aqueous paraformaldehyde, 0.1 M
cacodylate buffer, pH 7.4 containing 10 mM CaCl2 for 4 h at
20(C, then washed overnight at 4(C in 0.1 M cacodylate
buffer containing 50 mM BaCl2 and embedded in parafﬁn
27.
Five micrometer parafﬁn sections were deparafﬁnized in
xylene and rehydrated through ethanol before staining.
A hematoxylin and eosine counter staining was per-
formed to visualize cell body morphology. Additional
immunohistochemistry, using mAb directed against CD31
(monoclonal mouse anti-human, isotype IgG1 Kappa, Clone
551Osteoarthritis and Cartilage Vol. 13, No. 7Fig. 1. CD34 staining of the human meniscus. Schematic representation of the meniscus within the knee joint showing both the vascularized
outer third (vascular) as well as the avascular (avascular) part of the meniscus is shown in 1.5. Histological sections of four regions of interest
are presented (1.1e1.4). 1.1: Region located at the edge of the synovial-meniscus transition zone. The synovial lining itself is negative for both
CD34 (arrow) and CD31 (data not shown). The subsynovial ﬁbrous connective tissue is positive for CD34 but negative for CD31 (data not
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clonal mouse anti-human, isotype IgG1 Kappa, Clone
QBEnd 10, DAKO Cytomation Denmark) was performed
on the meniscus tissue sections. This was preceded by
intrinsic peroxidase blocking with H2O2 0.3% in methanol
for 10 min. Non-speciﬁc antibody sites were blocked by
10% human serum in PBS. Adequate isotype negative
controls (mouse IgG1 and IgG2a, 100 mg/L, DAKO, Car-
penteria, CA, USA) were used in the same concentration.
The sections were incubated with the mAb for 30 min at
room temperature. After washing, samples were treated
with biotinylated anti-mouse antibody, conjugated strepta-
vidin peroxidase and AEC chromogen for, respectively, 15,
15 and 10 min (LSABC system, DAKO).
STATISTICS
All experiments were done in threefold. Values obtained
for the different variables, i.e., accumulation of ECM
compounds, were expressed in meanG 1 SD. Increase in
DNA content during culture was depicted in Box-Whisker
plots. Data were analyzed statistically using SPSS (version
11.0) and Medcalc software. Student’s t test was used to
examine whether variables for the meniscus cell cultures
became signiﬁcantly different over time in culture or after
TGFb1 treatment. P-values of 0.05 were considered
signiﬁcant.
Results
MENISCUS TISSUE HISTOLOGY AND CYTOLOGICAL TYPING
Parafﬁn sections of full thickness meniscus tissue sample
clearly show the presence of both oval or round shaped
ﬁbrochondrocytes (Fig. 1.3 and 1.b) and spindle-shaped
ﬁbroblast-like meniscus cells (Fig. 1.2 and 1.a). The
ﬁbrochondrocyte is located in the avascular portion of the
meniscus and is situated in a lacuna surrounded by an
abundant ECM (Fig. 1.5). The ﬁbroblast-like cell on the
other hand is located in the outer portion of the meniscus
(Fig. 1.5). In this dense connective tissue vascular
structures can also be observed (Fig. 1.2). A synovial fold
is observed at the edges of the meniscus (Fig. 1.1). The
synovial sublining consists of a loose ﬁbrous tissue with
vascular structures.
Additional staining for speciﬁc membrane markers
revealed the existence of three distinct populations of
CD34 positive cells in the outer vascular portion of the
meniscus body (Fig. 1.2), the superﬁcial zone of the
meniscus (Fig. 1.c) as well as in the sublining of the syno-
vium. The ﬁrst of these CD34 positive cell populations has
a ﬁbroblast-like morphology, is mainly situated in the
synovial sublining and the outer portion of the meniscus
and is CD31 negative (Fig. 1.a). The synovial sublining
tissue is interdigitated with the vascular region of the
meniscus body. The second CD34 positive-CD31 negativepopulation is located in the superﬁcial zone of the meniscus
body and has a more round or oval shaped morphology
Fig. 1.c). The third distinct CD34 positive population is the
endothelial lining of the vascular structures and is positive
for CD31 (Fig. 1.1 and 1.2). The synovial lining (Fig. 1.1)
itself does not stain for these markers nor does the deeper,
avascular part of the meniscus body (Fig. 1.2 and 1.b).
CELL MORPHOLOGY AND PROLIFERATION IN VITRO
Meniscus cell morphology was studied on parafﬁn
embedded alginate sections or directly on in vitro cultured
cells using the inverted light microscopy. Cells seeded in
monolayer conditions attached within 24 h to the plastic
surface. Two different cell types could be observed initially:
round chondrocyte-like cells and ﬁbroblastic spindle-
shaped cells [Fig. 2(A)]. After 4e5 days the round
chondrocyte-like morphotype started to disappear from the
culture and after 1 week all cells had a ﬁbroblastic spindle-
shaped appearance. Cells suspended in alginate beads
were all round chondrocyte-like cells [Figs. 2(B) and 3].
These cells are located within lacunae (Fig. 3). Cell
morphology within the bead was uniformly stable for up to
10 weeks. After 3e4 weeks in alginate culture, small
cytoplasmatic projections could be observed in some cells.
Cells remained viable for up to 10 weeks of culture in
alginate beads.
Meniscus cells seeded in monolayer conditions ex-
panded logarithmically [Fig. 2(C)].
Meniscus cells cultured in alginate gel displayed a slight
decrease in cell number, as reﬂected in the total DNA
amount [Fig. 2(D)]. In the presence of TGFb1, however,
meniscus cells cultured in alginate initially showed an
increased proliferation [Fig. 2(E)].
MEMBRANE MARKERS OF MENISCUS CELLS CULTURED
IN ALGINATE
Flow cytometric analysis of meniscus cells cultured in
alginate reveals the presence of four distinct regions in the
PI/forward scatter (FSC) plot according to cell size (FSC,
X-axis) and PI staining intensity (PI, Y-axis): PI-positive
dead cells [Fig. 4(A), R1], PI-negative debris [Fig. 4(A), R2],
and two distinct populations of PI-negative viable cells
[Fig. 4(A), R3a and R3b]. R3a is clearly delineated from
R3b.
One day after enzymatic release, 80% and 15% of
meniscus cells in R3a were positive for CD44 and CD105,
respectively [Fig. 4(B)]. Less than 20% of these cells were
positive for CD34 while !5% was positive for CD31 and
CD45 [Fig. 4(B)]. The number of CD44 and CD105 positive
cells subsequently increased over time to over 90% and
70%, respectively [Fig. 4(B)]. These numbers became
stable around day 7 of culture, while the percentage ofshown), while the endothelial lining of the vascular elements is positive for both CD34 (arrowhead) and CD31 (inset 1.2). The superﬁcial as
well as the more deeper part of the outer one-third of the meniscus contain CD34 positive-CD31 negative ﬁbroblast-like cells. 1.2: Region
located within the vascularized one-third of the meniscus. The inset ﬁgure represents a deeper region within the vascularized part of the
meniscus stained for CD31. Vascular elements are observed within this region (arrowheads). Both endothelial lining as well as ﬁbroblast-like
cells stain positive for CD34. Only endothelial lining cells stain positive for CD31, while ﬁbroblast-like cells do not (inset). A higher
magniﬁcation of these ﬁbroblast-like cells is shown in 1.a (CD34 staining). 1.3: Region within the avascular part (1.5: avascular) of the
meniscus. Oval or round shaped ﬁbrochondrocytes situated within lacunae and surrounded by an abundant ECM, stain negative for CD34. A
magniﬁcation of these cells is presented in 1.b. 1.4: A superﬁcial region of the meniscus body (avascular region). Fusiform to round shaped
cells stain negative for CD31 (data not shown) and frequently positive for CD34. The deeper region of the meniscus however does not stain for
CD34 (asterix). A magniﬁcation of this superﬁcial region is presented in 1.c.
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Fig. 2. Morphology as observed with inverted microscope and growth characteristics of meniscus cells. A: Spindle-shaped monolayer cultured
(day 6) ﬁbroblast-like meniscus cells. A sporadic round cell can still be observed (arrowhead). B: Oval or round shaped chondrocyte-like
meniscus cells cultured in gelled alginate. C, D, E: Percentage increase in DNA content per culture in monolayer cultured meniscus cells (C),
in meniscus cells cultured in alginate gel (D) and in meniscus cells cultured in alginate when exposed to TGFb1 (E). Box plots are shown.
Percentage increases over weeks in monolayer culture were 24% (PZ 0.162), 155% (PZ 0.001), and 562% (PZ 0.0001) after 7, 14 and 21
days, respectively. Percentage changes in alginate culture were 14% (PZ 0.102), 4% (PZ 0.366), 13% (PZ 0.084) after 3, 6 and 14
days in culture, respectively. Percentage increases in alginate culture after exposure to TGFb1 were 34% (PZ 0.173), 41% (PZ 0.049) and
51% (PZ 0.030) after 3, 6 and 14 days in culture, respectively. Abscissae: culture time in days. Ordinates: amount of DNA (mg) per culture.
P-values result from one-sided t test on unpaired samples.CD34 positive cells steadily dropped to !5% at day 14
[Fig. 4(B)].
R3b contained 60% CD34 positive cells at initial
evaluation, and !5% of cells were positive for CD31 or
CD45 [Fig. 4(C)]. The percentage of CD34 positive cellsdropped to approximately 40% at day 7, while the
percentage of CD44 and CD105 positive cells increased
to 50% and 20%, respectively [Fig. 4(C)].
However, the absolute cell number in R3b decreased
steadily throughout the culture period and R3b disappeared
554 P. C. M. Verdonk et al.: Characterisation of human knee meniscus cell phenotypecompletely from the scatter plot after approximately 2
weeks of culture (Fig. 5).
Taken all together, the percentage of cells expressing the
different markers became stable after approximately 7 days
of culture in alginate gel [Fig. 4(B,C)].
THE CAM OF THE MENISCUS CELL IN ALGINATE
Cells isolated from meniscal tissue are not a homoge-
neous population. The two distinct populations of viable, PI-
negative cells that were identiﬁed as R3a and R3b
[Fig. 6(A)] when gated on the PI/FSC plot, were deﬁned
as CAM-coated cells and cells-without-CAM, respectively.
The CAM-coated cells express type I collagen in high
amounts, type II collagen in lower amounts and aggrecan in
high amounts [Fig. 6(C,D,E); Table I]. The cells-without-
CAM are devoid of collagen and aggrecan in their CAM
[Fig. 6(F,G,H); Table I].
The CAM proﬁle of the CAM-coated cells differs from the
proﬁle of the articular chondrocytes cultured in alginate.
The MFI values for type I collagen [Fig. 6(I)] are higher
in the former while type II collagen [Fig. 6(J)] MFIs are
lower. The CAM of articular chondrocytes contains higher
amounts of aggrecan [Fig. 6(K)] than the CAM of the CAM-
coated cells from meniscal tissue. Articular cartilage
chondrocytes and meniscus cells were obtained from the
same joint. Experiments performed on the respective tissue
cells of a second donor yielded exactly the same results.
An overview of the composition of the CAM of the 1-week
cultured CAM-coated cells and cells-without-CAM of six
different donors is given in Table I. The CAM expression
proﬁle of the CAM-coated cell population was followed for 3
weeks. The different meniscal cell samples varied widely in
their capacity to accumulate matrix components in the CAM
(Table I: coefﬁcient of variation (CV) on average MFI
values). Average cell MFI values due to the accumulation in
the CAM of type I collagen decreased slightly though
signiﬁcantly over 2 weeks of culture, to reach a plateau from
the second week on. The inverse was observed for CAM
type II collagen kinetics. Average cell MFI values due to the
accumulation in the CAM of aggrecan did not change over 3
weeks.
Fig. 3. Parafﬁn sections of meniscus cells cultured in alginate
(week 3). Oval or round shaped meniscus cells located in lacunae
can be observed.The level of aggrecan in the CAM of CAM-coated cells,
when cultured in the presence of TGFb1 (25 ng/ml) for 1
week, was signiﬁcantly upregulated with 103e303%
(PZ 0.042) (Table II). CAM-coated cells are therefore
capable to increase aggrecan production when cultured in
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Fig. 4. Expression of cell membrane markers by meniscus
ﬁbrochondrocytes during a 2-week culture period in gelled alginate.
A: PI/FSC plot according to cell size (FSC, X-axis) and PI staining
intensity (PI, Y-axis): R1: region 1 are PI-positive dead cells, R2:
region 2 are PI-negative debris. R3a and b: region 3a and b are two
distinct populations of PI-negative viable cells. B and C: Expression
of cell membrane markers by cells gated in R3a and R3b,
respectively. Abscissae: culture time in days. Ordinates: Percent-
age of positive cells.-: CD44;C: CD105;,: CD34;B: CD45; :
CD31; : negative control IgG.
555Osteoarthritis and Cartilage Vol. 13, No. 7type I collagen
type II collagen
aggrecan
C
D
E
type I collagen
type II collagen
aggrecan
F
G
H
forward scatter height
po
pi
di
um
 io
di
de
R1
R2
R3a
R3b
A
aggrecan
type II collagen
type I collagen
I
J
K
forward scatter height
po
pi
di
um
 io
di
de R1
R2 R3
B
fluorescence intensity
100 101 102 103 104
fluorescence intensity
100 101 102 103 104
fluorescence intensity
fluorescence intensity fluorescence intensity fluorescence intensity
fluorescence intensity fluorescence intensity fluorescence intensity
100 101 102 103 104
100 101 102 103 104 100 101 102 103 104 100 101 102 103 104
100 101 102 103 104 100 101 102 103 104 100 101 102 103 104
e
ve
n
ts
e
ve
n
ts
e
ve
n
ts
e
ve
n
ts
e
ve
n
ts
e
ve
n
ts
e
ve
n
ts
e
ve
n
ts
e
ve
n
ts
Fig. 6. Flow cytometric analysis of the CAM contents of human meniscus cells and articular cartilage chondrocytes. Donor: 55-year-old female.
Cells harvested after 1 week of primary culture in gelled alginate. PI/FSC plot of meniscus cells (A) and articular cartilage cells (B). See Fig. 4
legend for description of the regions of interest. Viable cells in R3a and b, and in R3 of dot plots A and B, respectively, were gated and
analyzed for their CAM contents. Fluorescence intensity histograms are presented showing the expression of type I collagen, type II collagen
and of aggrecan by viable meniscus cells in regions R3a (C,D,E) and R3b (F,G,H), and by viable articular cartilage chondrocytes gated in
region R3 (I,J,K), respectively. White curves: negative controls, Gray curves: mAbeFITC labeled cells. Abscissae: cell ﬂuorescence intensity.
Ordinates: events (cells) observed by the ﬂow cytometer.
Fig. 5. PI/FSC plot according to cell size (FSC, X-axis) and PI staining intensity (PI, Y-axis) of meniscus cells at distinct time points (day 0, 1, 3,
7, 14) and cultured in gelled alginate. Donor: 47-year-old male. The number of cells in region 3b (arrowhead) steadily decreased over the
culture period.
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Composition of the CAM of meniscus cells cultured in alginate. MFI values due to the presence of FITCemAb stained ECM compounds in
CAM-coated cells and in cells-without-CAM
Donor CAM-coated cells Cells-without-CAM
Week 1 Week 2 Week 3 Week 1
MeanG 1 SD MeanG 1 SD MeanG 1 SD MeanG 1 SD
Type I collagen
M69 9.99G 0.77 8.10G 1.64 20.38G 1.09 0.37G 0.14
M42 8.97G 0.62 7.56G 0.80 7.41G 0.67 0.48G 0.25
F69 28.02G 1.78 24.96G 0.91 25.57G 8.21 n.d.
M47 29.94G 3.96 25.08G 3.36 n.d. 3.84G 0.24
M65 22.35G 3.95 19.97G 6.33 14.60G 2.58 n.d.
F56 12.96G 2.08 n.d. n.d. 0.54G 0.23
Average 18.71G 9.27 17.13G 8.74 16.99G 7.80 1.31G 1.69
CV 51.01 51.02 45.91 129.01
P-value 0.0106 n.s. 0.0052
Type II collagen
M69 1.69G 0.07 3.24G 0.09 5.92G 0.18 0.30G 0.14
M42 3.14G 0.41 4.17G 0.83 3.99G 0.77 0.35G 0.25
F69 3.27G 0.58 5.16G 0.06 6.06G 1.52 n.d.
M47 4.59G 0.13 4.91G 0.16 n.d. 2.36G 0.46
M65 3.88G 0.58 4.20G 0.18 3.90G 0.71 n.d.
F56 2.65G 0.21 n.d. n.d. 0.34G 0.04
Average 3.20G 1.00 4.34G 0.75 4.97G 1.18 0.84G 1.02
CV 31.25 17.28 23.74 121.43
P-value 0.0324 n.s. 0.0095
Aggrecan
M69 4.59G 1.15 9.16G 1.02 16.12G 1.58 0.08G 0.14
M42 8.71G 1.69 7.12G 1.29 4.96G 1.08 0.28G 0.11
F69 21.09G 2.35 16.84G 3.60 16.18G 1.53 n.d.
M47 23.07G 2.83 29.57G 5.76 n.d. 1.38G 0.15
M65 20.36G 4.46 23.76G 9.89 10.92G 2.88 n.d.
F56 4.47G 0.72 n.d. n.d. 0.04G 0.05
Average 13.72G 8.72 17.29G 9.52 12.05G 5.33 0.45G 0.63
CV 63.56 55.06 44.23 140.00
P-value n.s. n.s. 0.0134
Donor: Sex/age are given; meanG 1 SD for all individual experiments in triplicate are given in the table; bottom lines: Average:
meanG 1 SD for all meniscus cell cultures. CV (1 SD! 100/mean) for the averages of the respective variables. The different meniscal cell
samples vary widely in their capacity to accumulate matrix components in the CAM. P-values: two-sided t test was done to test for differences
in accumulation of ECM products by CAM-coated cells over 3 weeks. t test for paired samples was done to evaluate differences in
accumulation of ECM products by CAM-coated cells and cells-without-CAM at week 1.alginate. A trend to increase was observed in the
expression of type II collagen (range 6.5e21.3%,
PZ 0.060), while no clear effects could be noted in the
expression of type I collagen.
THE CAM OF MONOLAYER CULTURED MENISCUS CELLS
Flow cytometric analysis of meniscus cells cultured in
monolayer conditions reveals only three distinct popula-
tions: PI-positive dead cells, PI-negative debris and PI-
negative living cells . The CAM of the monolayer cultured
meniscus cells contains high amounts of type I and II
collagen [Fig. 7(A,B)] and almost no aggrecan [Fig. 7(C)].
The levels of type II collagen are however lower than type I
collagen. Speciﬁc MFI values for the three matrix compo-
nents in three different donors are presented in Table III.
The CAM proﬁle of meniscus cells cultured as monolayer is
therefore distinctly different from the CAM proﬁle of cells
derived from the same donor but cultured in alginate
[Fig. 7(D,E,F)]; alginate cultured CAM-associated-cells
have high amounts of type I collagen and aggrecan and
low amounts of type II collagen in their CAM.When assessed over a 2-week culture period, aggrecan
was apparently downregulated in monolayer cultured
meniscus cells (Table III, PZ 0.057), whereas no changes
were observed for both collagen types (Table III)
Discussion
Human meniscus tissue is said to be populated mainly by
round or oval matrix associated cells, comparable to the
articular cartilage chondrocyte, and ﬁbroblast-like cells10.
The round or oval cells of the meniscus, however, produced
more type I collagen than the articular chondrocytes4. The
major ﬁbrillar collagen produced by chondrocytes from the
articular cartilage is type II collagen. Hence, this meniscus
cell was termed a ﬁbrochondrocyte based on the difference
in expression of collagen types4. Two other connective
tissue cell types have been described in meniscus tissue
according to their shape, location and presence of ECM: the
superﬁcial cell and a cell type of intermediate morphology
between that of a ﬁbrochondrocyte and ﬁbroblasts10,28.
557Osteoarthritis and Cartilage Vol. 13, No. 7Little is known about the cellular biology of the human
meniscus or of these different distinct cell populations
present in this tissue. Difﬁculties still arise when attempts
are made to isolate and to characterize these different
meniscus cell types in vitro. The cellular phenotype can be
modulated by different culture conditions and certain culture
conditions can favor one phenotype over another. Most
data available are derived from whole tissue explant
cultures or from monolayer cultured cells where protein
and mRNA levels are obtained from collections of
cells29e32. No speciﬁc data, however, exists on the cellular
protein expression level.
To our knowledge, this is the ﬁrst study performed on
isolated human meniscus cells, cultured in different
conditions, where the production of the ECM is analyzed
using ﬂow cytometric analysis of the CAM. Flow cytometry
allows study of the composition of the CAM of connective
tissue cells12,33,34. This technique has allowed protein
expression in the CAM of articular cartilage chondrocytes
to be analyzed on a cellular level. After staining with the
appropriate speciﬁc mAbs, the composition of the CAM of
single cells has been analyzed and quantiﬁed according to
their ﬂuorescence intensity15,33. This CAM is a distinct part
of the territorial matrix of the cell. Although the distribution
and turnover of the ECM have been shown to differ in the
territorial and interterritorial matrix of articular cartilage cells,
the CAM has been shown to represent about 25% of the
newly formed ECM of these cells in culture35,36. The
contents of the CAM, e.g., type I collagen, type II collagen
and aggrecan, have been considered to deﬁne the instant
cellular phenotype of articular cartilage cells33. Since no
known standard exists, the CAM composition of meniscus
cells cultured in different conditions was eventually com-
pared to that of phenotypically stable human articular
chondrocytes cultured in alginate37. Human articular chon-
drocytes are said to be phenotypically stable when
maintained in gelled alginate37. The same articular chon-
drocytes cultured in monolayer conditions loose their
chondrocyte speciﬁc characteristics and gain a more
ﬁbroblast-like appearance. This process is termed de-
differentiation and has been described numerous times on
Table II
Influence of TGFb1 on type I and II collagen and on aggrecan
production in 1-week cultured CAM producing meniscus cells in
alginate
Controls TGFb1 Difference (%) P-value
MeanG 1 SD MeanG 1 SD
Type I collagen
F69 28.02G 1.78 23.66G 2.76 15.56
F56 12.96G 2.08 15.04G 0.55 16.05 0.328
M69 9.99G 0.77 9.37G 0.06 6.26
Type II collagen
F69 3.27G 0.58 3.59G 2.76 9.90
F56 2.65G 0.21 3.21G 0.55 21.28 0.060
M69 1.69G 0.07 1.81G 0.06 6.59
Aggrecan
F69 21.09G 2.35 42.96G 2.12 103.75
F56 4.47G 0.72 18.02G 0.93 303.06 0.042
M69 4.59G 1.15 11.34G 1.15 147.06
Donors: Sex/Age are given; Mean valuesG 1 SD for Cell Median
Fluorescence Intensities are given for the three ECM components
and for three donors; experiments done in triplicate. P-values result
from one-sided t tests on paired samples.the cellular protein level, as well as on whole culture protein
and mRNA levels38e40. Typically, type I collagen production
by these cells was upregulated, and type II collagen
together with aggrecan downregulated15. As hydrogels
such as alginate or agarose are considered the artiﬁcial
matrix of choice to culture phenotypically stable articular
cartilage chondrocytes, the alginate gel was ﬁnally chosen
for meniscus cell culture. It was hypothesized that this
culture model could possibly stabilize the meniscus
ﬁbrochondrocyte phenotype. Others have already demon-
strated that isolated meniscus cells cultured in alginate
synthesize proteoglycans similar to explant cultures in
amount and composition, indicating a phenotype resem-
bling the native situation8.
With ﬂow cytometry, we have analyzed the cells present
in the human meniscus after culture for up to 3 weeks in
alginate, and initially found two cell populations surviving
the isolation procedure. A minor fraction consisting of CD34
positive-CD31 negative cells was mainly derived from the
vascular portion of the meniscus body and was probably
unable to remain viable in the alginate gel. However, the
exact fate of this population in culture remains to be
determined. This cell population also did not accumulate
signiﬁcant amounts of ECM products in its CAM. Additional
histology on human meniscus tissue conﬁrmed the pres-
ence of CD34 positive-CD31 negative ﬁbroblast cells in the
vascular portion of the meniscus as well as the synovial
sublining. Surprisingly, CD34 positive-CD31 negative cells
were also observed in the superﬁcial region of the meniscus
body. These cells had a fusiform or more round/oval
shaped morphology. It has been hypothesized previously
that the CD34 positive-CD31 negative population, residing
in the synovial sublining represents a possible pool of
endothelial progenitor cells responsible for vasculogene-
sis41. The intriguing possibility has been raised previously
that the superﬁcial zone contains specialized cells, perhaps
progenitor cells, that could initiate wound-healing42,43.
Further research is however necessary to elucidate the
exact phenotype and function of this cell population. CD34
positive-CD31 positive cells were only observed within the
vascular structure and are considered mature endothelial
cells.
The main fraction of isolated meniscus cells persisted in
culture, accumulated signiﬁcant amounts of ground sub-
stance in its immediate pericellular environment and
displayed a stable phenotype. These cells were CD34
negative-CD31 negative. Morphologically, these round or
oval shaped cells were very similar to the meniscus
ﬁbrochondrocyte. CAM composition consisted of high
amounts of both type I collagen and aggrecan and low
amounts of type II collagen. This composition resembles the
native composition of the human meniscus ECM. Overall,
the proportion of type I collagen to type II collagen is said to
be approximately 9 to 1 in meniscus tissue4,44. However,
this proportion is known to vary considerably depending on
the meniscus region. The proportion of type I to type II
collagen in the inner meniscus is for example 1 to 1.545.
In this paper, interpretation of the ﬂow cytometric results
on cells maintained in alginate shows a proportion between
3 and 6 to 1 (type I to type II collagen). One should take into
account (1) that this is only the CAM and not the complete
matrix and (2) this is newly synthesized matrix since these
cells have been isolated enzymatically, whereas values
obtained in mature tissue are these of an ECM in
homeostasis. The high proportions of aggrecan relative to
that of type I collagen can be explained in a similar fashion
as for articular cartilage chondrocytes. Metabolical half-life
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Fig. 7. Flow cytometric analysis of human meniscus cells. Donor: 55-year-old female. Cells harvested after 1 week of primary culture as
monolayer (left histograms) or in gelled alginate (right histograms). Histograms show the expression of type I and II collagen and of aggrecan
in monolayer cultured meniscus cells (A,B,C) and the expression of type I and II collagen and of aggrecan in meniscus cells that were
maintained in culture in gelled alginate (D,E,F). White curves: negative controls, Gray curves: mAbeFITC labeled cells. Abscissae: cell
ﬂuorescence intensity. Ordinates: events (cells) observed by the ﬂow cytometer.of aggrecan is known to be much shorter than that of
collagen molecules46,47. Therefore, to obtain a stable
amount of aggrecan in the ECM, aggrecan production has
to be higher than collagen production.
When compared to articular cartilage chondrocytes, the
biosynthesis and accumulation of ECM compounds in the
CAM of meniscus cells is clearly different: more type I
collagen is synthesized, less type II collagen and aggrecan.
Hence, the meniscus cell maintained in alginate appears to
be a unique cell type with a unique CAM composition.
Furthermore, our results indicate that TGFb1 increases cell
proliferation and the synthesis of type II collagen and
aggrecan. TGFb1 is known to induce a similar increase in
production of collagen type II and aggrecan in articular
chondrocytes48, intervertebral disc cells49 and chondropro-
genitor cells50e52. It is therefore generally accepted that
TGFb1 promotes a chondrogenic phenotype. Others also
observed an increase in aggrecan synthesis rates, an
aggregation of aggrecan monomers in hyaluronan/aggrecan
complexes and an increase in the production of the larger of
the two small proteoglycans, putatively biglycan, in alginate
cultures of meniscus cells, in the presence of TGFb18.The monolayer culture condition, known to induce
articular chondrocyte dedifferentiation towards a more
ﬁbroblast-like cell type, resulted in a completely different
CAM composition of the meniscus cell when compared to
meniscus cell cultured in alginate. Aggrecan levels in the
CAM were dramatically lower while type II collagen
synthesis apparently was upregulated. Monolayer cultured
meniscus cells all had a ﬁbroblast-like morphology.
Previous reports on monolayer cultured meniscus cells
indeed indicate a signiﬁcant and rapid decrease in
synthesis of large aggregating proteoglycans, irrespective
of the meniscus region from where they were derived8.
No deﬁnite explanation can be given for the observed
difference between monolayer cultured meniscus cells and
those cells cultured in alginate. In light of the current
knowledge on meniscus cell biology in situ and the different
cell types present in the meniscus, it is tempting to state that
both culture models favor the existence of a different
meniscus cell type43. Anchorage independent cells such as
articular chondrocytes and most probably meniscus ﬁbro-
chondrocytes thrive in the alginate culture conditions, while
anchorage dependent cells such as meniscus ﬁbroblast-like
559Osteoarthritis and Cartilage Vol. 13, No. 7cells would prefer monolayer culture conditions. It is
therefore possible that meniscus ﬁbroblast-like cells over-
grow meniscus ﬁbrochondrocytes in the monolayer condi-
tion. A second hypothesis could be that the
ﬁbrochondrocyte morphology and CAM composition can
be modulated by the different culture conditions, as is
generally accepted for the articular cartilage chondrocyte.
This knowledge can be applied in cell-based tissue
engineering applications. The biochemical and biomechan-
ical characteristics of an engineered tissue are ultimately
deﬁned by the cell phenotype and should resemble native
tissue.
In conclusion, these studies aimed at the characterization
of the human meniscus cell’s CAM synthesis and turnover
in two different culture conditions. The composition of this
ECM offers a variable deﬁning the distinct phenotype of the
cells homing in the meniscus. The alginate culture
conditions appear to favor the ﬁbrochondrocyte meniscus
cell with a CAM rich in type I collagen and aggrecan and
lower quantities of type II collagen, while monolayer
cultured meniscus cells have considerable amounts of type
I and II collagen but almost no aggrecan in their CAM. This
CAM composition is distinctly different from the CAM
composition of phenotypically stable articular cartilage
chondrocytes. These studies warrant further research into
in vitro meniscus cell behavior and further deﬁnition of the
different meniscus cell types.
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